Minimal access closure of patent foramen ovale: Is it also recommended for patients with paradoxical emboli?

Annals of Thoracic Surgery

Volumn 74, Issue 4, 2002, Pages 1326-1329

  Deeik, Ramzi K ^a   Thomas, Ryan M ^a   Sakiyalak, Pranya ^a   Botkin, Sally ^a   Blakeman, Bradford ^a   Bakhos, Mamdouh ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA OCCLUSION; BLEEDING; BRAIN INFARCTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HUMAN; LUNG EMBOLISM; MALE; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; STERNOTOMY; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036798924     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4975(02)03964-4     Document Type: Conference Paper

References (12)

1. Caes FL, Van Belleghem YV, Missault LH, Coenye KE, Van Nooten GJ. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 1995;59:1559-61.
2. Mas JL, Zuber M, French Study Group on Patent Foramen Ovale, and Atrial Septal Aneurysm. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J 1995;130:1083-8.
3. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G, Lausanne Stroke with Paradoxical Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology 1996;46:1301-5.
4. Black MD, Freedom RM. Minimally invasive repair of atrial septal defects. Ann Thorac Surg 1998;65:765-7.
5. Massetti M, Babatasi G, Rossi A, et al. Operation for atrial septal defect through a right anterolateral thoracotomy: current outcome. Ann Thorac Surg 1996;62:1100-3.
6. Rickers C, Hamm C, Stern H, et al. Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings"). Heart 1998;80:517-21.
7. Lloyd TR, Rao PS, Beekman RH 3rd, Mendelsohn AM, Sideris EB. Atrial septal defect occlusion with the buttoned device (a multi-institutional U.S. trial). Am J Cardiol 1994;73:283-91.
8. Bohm J, Bittigau K, Kohler F, Baumann G, Konertz W. Surgical removal of atrial septal defect occlusion system-devices. Eur J Cardiothorac Surg 1997;12:869-72.
9. Sievert H. Catheter closure of congenital shunts. Cor Europaeum 1998;7:59-73.
10. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-8.
11. Murphy JG, Gersh BJ, McGoon et al. Long term outcome after surgical repair of isolated atrial septal defect. Follow up at 27 to 32 years. N Engl J Med 1990;323:1645-50.
12. Fischer G, Kramer HH, Stieh J, Harding P, Jung O. Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer septal occluder. Eur Heart J 1999;20:541-9.